Trial description:
A randomised phase III trial to evaluate the duration of anti-PD1 monoclonal antibody treatment in patients with metastatic melanoma
Contact name:
Dr Pippa Corrie
Trial start date:
Friday, September 21, 2018
Trial end date:
Friday, March 31, 2023
Trial tumour type:
Skin & melanoma
Show on Radiotherapy:
No
